Table VI.
Effects of the intake of heat-killed L. brevis SBC8803 on the levels of TEWL.
| Position | Group | Screening | Week 4 | Week 8 | Week 12 |
|---|---|---|---|---|---|
| Forearm | P | 9.4±2.1 | 8.8±2.3a | 8.6±2.8 | 9.2±2.1 |
| (−0.5±1.6) | (−0.7±2.4) | (−0.1±2.0) | |||
| L | 9.4±2.1 | 9.5±2.2 | 8.7±2.0a | 9.9±2.3 | |
| (0.1±2.2) | (−0.7±2.1) | (0.4±2.1) | |||
| H | 9.5±1.7 | 9.6±1.9 | 8.8±2.0b | 9.4±2.1 | |
| (0.1±1.5) | (−0.8±1.5) | (−0.1±1.8) | |||
| Neck | P | 9.6±4.0 | 10.0±3.7 | 9.9±4.8 | 9.5±3.1 |
| (0.3±2.7) | (0.3±3.8) | (−0.1±4.0) | |||
| L | 10.6±7.0 | 10.7±5.7 | 9.0±3.7a | 9.9±3.4 | |
| (0.1±4.7) | (−1.7±4.8c) | (−0.8±5.4) | |||
| H | 10.0±4.1 | 10.0±3.3 | 9.1±3.4 | 10.1±4.1 | |
| (0.0±3.2) | (−0.9±3.2) | (0.1±3.4) | |||
| Lower eye region | P | 24.5±8.0 | 20.8±5.3b | 20.4±4.8b | 20.0±5.2b |
| (−3.6±8.0) | (−4.1±7.8) | (−4.5±8.8) | |||
| L | 25.1±8.0 | 21.0±6.4b | 21.2±6.0b | 19.7±5.8b | |
| (−4.0±6.5) | (−3.8±6.7) | (−5.3±7.7) | |||
| H | 23.1±7.2 | 22.5±6.9 | 21.1±5.6 | 20.6±4.8a | |
| (−0.6±6.1c) | (−2.0±6.5) | (−2.5±6.1) |
Each value (g/m2h) represents the mean ± standard deviation, and the difference from the screening value is shown in parenthesis.
a
P<0.05
b
P<0.01 by intragroup comparison using paired Student's t-test.
c
P<0.1 by intergroup comparison using Dunnett's test using the value of group P as a reference. Group P, placebo group; group L, 25 mg/day heat-killed L. brevis SBC8803 group; group H, 50 mg/day heat-killed L. brevis SBC8803 group; L. brevis, Lactobacillus brevis.